Drugs / AZITROMYCIN
Trials 0
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03863249 Comparator | Feb 2019 → May 2022 | chronic periodontitis, primary bacterial infectious disease | University of Valencia | Completed | No outcome recorded |
| Phase 4 | NCT01241110 Comparator | Jan → Aug 2010 | pelvic inflammatory disease | Guilan University of Medical Sciences | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AZITROMYCIN | “The antibiotic will be selected among AMOXICILIN, METRONIDAZOLE, AMOXICILIN + METRONIDAZOLE AND AZITROMYCIN.” NCT03863249 ↗ |
| Route | Oral | “a single dose of oral Azitromicine” NCT01241110 ↗ |